Discover investment opportunities in Top Precision Medicine Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top Precision Medicine Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top Precision Medicine Stocks using our Smart AI Filter.
9 stocks found for "Top Precision Medicine Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.50 | ±64.8% | -8.0 | 0.00% | |||
1.02 | ±49.1% | 40.9 | 0.00% | |||
1.92 | ±68.6% | -1.9 | 0.00% | |||
1.34 | ±55.5% | -10.4 | 0.00% | |||
0.89 | ±41.9% | 22.8 | 0.00% | |||
0.37 | ±22.9% | 21.1 | 0.52% | |||
1.77 | ±71.4% | -18.6 | 0.00% | |||
1.19 | ±53.7% | -156.9 | 0.00% | |||
0.63 | ±47.5% | -28.2 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What are the growth prospects for Illumina (ILMN) in the precision medicine market?
A: Illumina (ILMN) is a leading player in genomics, providing sequencing systems that are integral to precision medicine. Their technology is crucial for diagnostics and personalized treatments. Investors usually view continued innovation and expanding applications in genomics as growth drivers for Illumina.
Q: How does Vertex Pharmaceuticals (VRTX) contribute to precision medicine?
A: Vertex Pharmaceuticals (VRTX) specializes in developing precision medicines for cystic fibrosis and other serious diseases. Their approach targets underlying genetic causes, enhancing treatment specificity and efficacy. This focus aligns them closely with the personalized medicine paradigm.
Q: What risks are associated with investing in CRISPR Therapeutics (CRSP)?
A: CRISPR Therapeutics (CRSP) engages in gene editing, a field subject to significant scientific and regulatory risks. Uncertainties include clinical trial outcomes, patent disputes, and ethical considerations, all of which may impact financial performance and stock volatility.
Q: Are Regeneron Pharmaceuticals (RGEN) stocks considered good for investors focusing on groundbreaking therapies?
A: Regeneron Pharmaceuticals (RGEN) develops innovative therapies in areas like oncology and inflammation, often pioneering novel treatment approaches. Such groundbreaking efforts can attract investors looking for high-impact medical innovation and long-term growth potential.
Q: What makes Intellia Therapeutics (NTLA) a notable stock in precision medicine?
A: Intellia Therapeutics (NTLA) focuses on in vivo gene editing technologies. Their advancements in CRISPR-based therapies are designed to treat genetic diseases directly inside the patient’s body, which may lead to transformative health outcomes and attract growth-focused investors.
Q: How does Guardant Health (GH) enhance precision medicine through diagnostics?
A: Guardant Health (GH) offers non-invasive cancer diagnostics using liquid biopsies, enabling early detection and monitoring. Their innovative approach aligns with precision medicine by providing critical insights into a patient's tumor profile, which can guide tailored treatment strategies.